229 related articles for article (PubMed ID: 26743751)
1. En face OCT in Stargardt disease.
Sodi A; Mucciolo DP; Cipollini F; Murro V; Caporossi O; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1669-79. PubMed ID: 26743751
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence in Stargardt Disease.
Greenstein VC; Nunez J; Lee W; Schuerch K; Fortune B; Tsang SH; Allikmets R; Sparrow JR; Hood DC
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5227-5236. PubMed ID: 29049723
[TBL] [Abstract][Full Text] [Related]
4. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
5. The dark atrophy with indocyanine green angiography in Stargardt disease.
Giani A; Pellegrini M; Carini E; Peroglio Deiro A; Bottoni F; Staurenghi G
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3999-4004. PubMed ID: 22589445
[TBL] [Abstract][Full Text] [Related]
6. The Rapid-Onset Chorioretinopathy Phenotype of ABCA4 Disease.
Tanaka K; Lee W; Zernant J; Schuerch K; Ciccone L; Tsang SH; Sparrow JR; Allikmets R
Ophthalmology; 2018 Jan; 125(1):89-99. PubMed ID: 28947085
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of multimodal imaging in the various stages of Stargardt disease].
El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
[TBL] [Abstract][Full Text] [Related]
8. The absence of fundus abnormalities in Stargardt disease.
Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
[TBL] [Abstract][Full Text] [Related]
9. Outer nuclear layer relevance in visual function correlated to quantitative enface OCT parameters in Stargardt disease.
Mucciolo DP; Lippera M; Giorgio D; Sodi A; Passerini I; Cipollini F; Virgili G; Giansanti F; Murro V
Eur J Ophthalmol; 2021 Nov; 31(6):3248-3258. PubMed ID: 33508977
[TBL] [Abstract][Full Text] [Related]
10. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
Cai CX; Light JG; Handa JT
Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
[TBL] [Abstract][Full Text] [Related]
12. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
[TBL] [Abstract][Full Text] [Related]
13. Foveal sparing in Stargardt disease.
van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
[TBL] [Abstract][Full Text] [Related]
14. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
15. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.
Gomes NL; Greenstein VC; Carlson JN; Tsang SH; Smith RT; Carr RE; Hood DC; Chang S
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3953-9. PubMed ID: 19324865
[TBL] [Abstract][Full Text] [Related]
16. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular characteristics of childhood-onset Stargardt disease.
Fujinami K; Zernant J; Chana RK; Wright GA; Tsunoda K; Ozawa Y; Tsubota K; Robson AG; Holder GE; Allikmets R; Michaelides M; Moore AT
Ophthalmology; 2015 Feb; 122(2):326-34. PubMed ID: 25312043
[TBL] [Abstract][Full Text] [Related]
18. Progression of Late-Onset Stargardt Disease.
Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Outer Retinal Degeneration and Choriocapillaris Loss in Stargardt Disease Using En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography.
Alabduljalil T; Patel RC; Alqahtani AA; Gao SS; Gale MJ; Zhang M; Jia Y; Huang D; Chiang PW; Chen R; Wang J; Weleber RG; Pennesi ME; Yang P
Am J Ophthalmol; 2019 Jun; 202():79-90. PubMed ID: 30771335
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
